Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immuron Limited ( (AU:IMC) ) has shared an announcement.
Immuron Limited has announced the quotation of 877,440 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective from July 17, 2025. This move is part of previously announced transactions and could potentially enhance the company’s market presence and liquidity, impacting its stakeholders positively.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapeutic products for the treatment of immune-mediated diseases.
Average Trading Volume: 78,544
Technical Sentiment Signal: Sell
Current Market Cap: A$14.97M
For detailed information about IMC stock, go to TipRanks’ Stock Analysis page.